ERBB2 and breast carcinoma: In this study, the efficacy of MAHNP-DOX was evaluated and compared with that of free DOX using HER2-positive human breast cancer cells BT474 and SKBR3 as in vitro model systems and nude mice with BT474 xenografts as an in vivo model.